Projects per year
Projects 1993 2023
Active
A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector Mediated Gene Transfer of Human Factor VIII at a dose of 4E13 vg/kg inHemophilia A Patients with Residual FVIII Levels
7/15/18 → 7/15/23
Project: Research project
Transfer Factor
Dependovirus
Hemophilia A
Safety
Genes
A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Levels...
5/1/18 → 7/15/23
Project: Research project
Transfer Factor
Dependovirus
Hemophilia A
Safety
Genes
Factor VIII
Hemophilia A
Hemorrhage
Patient Reported Outcome Measures
ECHO: Expanding Communications on Hemophilia-A Outcomes.
BAYER HEALTHCARE PHARMACEUTICALS
7/1/16 → 12/31/21
Project: Research project
Hemophilia A
Registries
Patient Reported Outcome Measures
Phase I/II/III Pharmacokinetic and Outcome Study of Insp
Inspiration Biopharmaceuticals, Inc.
5/14/10 → 12/31/20
Project: Research project
Hemophilia B
Factor IX
Pharmacokinetics
Outcome Assessment (Health Care)
IB1001
Safety
Finished
United States Health Resources and Services Administration
United States Health Resources and Services Administration
Phase III Clinical Trials
Hemophilia A
Pharmacokinetics
Safety
Hemophilia B
Factor IX
Blood Coagulation Factors
Factor VIII
Hemophilia A
My Life Our Future: A Hemophilia Genotyping Initiative D
AMERICAN THROMBOSIS & HEMOSTATIS NETWORK
11/1/13 → 12/31/18
Project: Research project
An Observational Study of Postoperative Deep Venous Thro
THE UNIV. OF N. CAROLINA AT CHAPEL HILL
11/5/12 → 4/2/19
Project: Research project
Venous Thrombosis
Observational Studies
Orthopedics
Hemophilia B
Dependovirus
Factor IX
Genetic Therapy
Serogroup
A Phase 1/2 Open-Label, Single Ascending Dose Trial of a
ASKLEPIOS Biopharmaceutical, Inc.
5/30/12 → 5/30/17
Project: Research project
Hemophilia B
Factor IX
Genetic Therapy
Viruses
Serogroup
A Phase II/III, multicenter, partially randomized, open
BAYER HEALTHCARE PHARMACEUTICALS
4/24/12 → 12/31/18
Project: Research project
Hemophilia A
Safety
BAY 94-9027
Type 3 Von Willebrand's Disease
Factor VIII
Safety
Clinical Studies
human F8 protein
Public Health Surveillance
Hemorrhage
Hemophilia A
Hemorrhage
Safety
Therapeutics
An open-label Phase I trial to evaluate the pharmacokine
BAYER HEALTHCARE PHARMACEUTICALS
6/1/10 → 5/31/13
Project: Research project
Hemophilia A
Pharmacokinetics
Safety
BAY 94-9027
National Hemophilia Foundation's National Prevention Program
10/15/08 → 12/31/10
Project: Research project
Hemophilia A
Hemophilia A
Observational Studies
TMH 04: High Dose Granulocyte Transfusions for the Treat
Mc Cullough, J., Reding, M. T. & Steiner, M. E.
New England Research Institutes
1/1/08 → 12/31/13
Project: Research project
Neutropenia
Granulocytes
Infection
Randomized, controlled, parallel, prospective trial to e
Pharmaceutical Product Development, Inc.
1/1/08 → 12/31/13
Project: Research project
Hemophilia A
Therapeutics
Clinical Trials in Transfusion Medicine and Hemostasis
Mc Cullough, J., Clay, M. & Reding, M. T.
NIH Nat'l Heart, Lung, and Blood Inst.
9/1/07 → 8/31/14
Project: Research project
Transfusion Medicine
Hemostasis
Clinical Trials
MASTER: TMH Network Master Site Agreement
Mc Cullough, J., Clay, M., Reding, M. T. & Steiner, M. E.
New England Research Institutes
9/1/07 → 8/31/14
Project: Research project
TMH Network Master Site Agreement - HIT Observational Th
Mc Cullough, J., Reding, M. T. & Steiner, M. E.
New England Research Institutes
9/1/07 → 8/31/12
Project: Research project
Determination of the Optimal Prophylactic Platelet Dose
Mc Cullough, J., Reding, M. T. & Steiner, M. E.
New England Research Institutes
9/1/07 → 8/31/12
Project: Research project
Blood Platelets
Hemorrhage
Hemophilia A
BOEC and SBTn for Gene Therapy
Hebbel, R. P., Key, N., Kren, B. J., Reding, M. T. & Steer, C. J.
7/1/06 → 6/30/10
Project: Research project
Genetic Therapy
Serum Albumin
human F8 protein
Upper Midwest Hemophilia Diagnostic & Treatment Center Health Resources and Services Administration Grant
6/1/05 → 5/31/17
Project: Research project
United States Health Resources and Services Administration
Hemophilia A
Factor VIII
Genetic Therapy
Hemophilia A